Ortivus AB (publ) (STO:ORTI.B)
Sweden · Delayed Price · Currency is SEK 1.545
+0.020 (1.31%)
At close: Apr 23, 2026
Ortivus AB Market Cap
Ortivus AB has a market cap or net worth of 137.6 million as of April 24, 2026. Its market cap has increased by 75.44% in one year.
Market Cap
137.60M
Enterprise Value
148.24M
Revenue
73.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since March 2, 1998, Ortivus AB's market cap has decreased from 1.69B to 137.60M, a decrease of -91.84%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 137.60M | 27.63% |
| Dec 30, 2025 | 107.81M | 66.21% |
| Dec 30, 2024 | 64.86M | -60.95% |
| Dec 29, 2023 | 166.09M | -32.54% |
| Dec 30, 2022 | 246.21M | 6.08% |
| Dec 30, 2021 | 232.10M | 1.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 53.38B |
| Sectra AB | 52.14B |
| Camurus AB | 33.97B |
| Boule Diagnostics AB | 153.00M |
| Clinical Laserthermia Systems AB | 144.63M |
| Immunovia AB | 134.53M |
| NextCell Pharma AB | 133.67M |